Advertisement

Topics

Rivaroxaban Fails in Study of Recurrent Embolic Stroke of Unknown Source

09:03 EDT 17 May 2018 | NEJM

Compared with aspirin, rivaroxaban did not prevent recurrent ischemic strokes and was associated with more bleeding complications.

Original Article: Rivaroxaban Fails in Study of Recurrent Embolic Stroke of Unknown Source

NEXT ARTICLE

More From BioPortfolio on "Rivaroxaban Fails in Study of Recurrent Embolic Stroke of Unknown Source"

Advertisement
Quick Search
Advertisement
Advertisement